Literature DB >> 9637482

The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.

K Kim1, C K Lee, T J Sayers, K Muegge, S K Durum.   

Abstract

Signals from the IL-7R are essential for normal thymocyte development. We isolated thymocytes from early developmental stages and observed that suspensions of pro-T1, -T2, and -T3 cells rapidly died in culture. Addition of IL-7 promoted their survival, but did not induce cell division. Pro-T4 cells did not undergo rapid cell death, and their survival was therefore independent of IL-7. Death in the absence of IL-7 showed the hallmarks of apoptosis, including DNA fragmentation and annexin V binding; however, caspase inhibitors blocked DNA fragmentation, but did not block cell death. The trophic effect of IL-7 was partially inhibited by blocking protein synthesis. The p53 pathway was not involved in this death pathway, since pro-T cells from p53-/- mice also underwent cell death in the absence of IL-7. The Fas/Fas ligand pathway was not involved in cell death, since Fas-deficient pro-T cells died normally in the absence of IL-7, anti-Fas Abs did not protect cells from death in the absence of IL-7, and Fas expression was undetectable on cells at these stages. The IL-7 trophic affect correlated with increased intracellular levels of Bcl-2 and decreased levels of Bax, whereas no Bcl-X(L), Bcl-w, or Bad was detectable. Thus, maintaining a favorable Bcl-2/Bax ratio may account for the trophic action of IL-7.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637482

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH.

Authors:  A R Khaled; K Kim; R Hofmeister; K Muegge; S K Durum
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 2.  Reversing T cell immunosenescence: why, who, and how.

Authors:  Pierre Olivier Lang; Sheila Govind; Richard Aspinall
Journal:  Age (Dordr)       Date:  2012-02-26

3.  c-Cbl deficiency leads to diminished lymphocyte development and functions in an age-dependent manner.

Authors:  Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

4.  IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.

Authors:  C C Walline; S Kanakasabai; J J Bright
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

5.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

Review 6.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

8.  Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.

Authors:  A R Khaled; A N Moor; A Li; K Kim; D K Ferris; K Muegge; R J Fisher; L Fliegel; S K Durum
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Ex vivo expansion of memory CD8 T cells from lymph nodes or spleen through in vitro culture with interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  J Immunol Methods       Date:  2009-03-17       Impact factor: 2.303

10.  Development of regulatory T cells requires IL-7Ralpha stimulation by IL-7 or TSLP.

Authors:  Renata Mazzucchelli; Julie A Hixon; Rosanne Spolski; Xin Chen; Wen Qing Li; Veronica L Hall; Jami Willette-Brown; Arthur A Hurwitz; Warren J Leonard; Scott K Durum
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.